DudeDiligence.

Crinetics Pharmaceuticals Inc

CRNXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$13.4M

19 notices · 344,009 sh

Reported ·

$6,511,702

18 sales · 0 buys

The two figures cover different periods.

All 18 reported sales carry the 10b5-1 box. Together they are 0.16% of the shares on issue.

PLANNED · FORM 144REPORTED · FORM 4N2025DJ2026FMAMJJASO2026-07-02: JEFF KNIGHT, Form 1442026-07-02: ROGERIO VIVALDI COELHO, Form 1442026-06-17: STEPHANIE OKEY, Form 1442026-05-04: JEFF KNIGHT, Form 1442026-04-14: JEFF KNIGHT, Form 1442026-04-13: JEFF KNIGHT, Form 1442026-04-08: JEFF KNIGHT, Form 1442026-03-18: DANA PIZZUTI, Form 1442026-03-16: Jeff Knight, Form 1442026-03-16: Stephen Betz, Form 1442026-03-16: Richard Scott Struthers, Form 1442026-03-12: ROGERIO VIVALDI COELHO, Form 1442026-03-03: STEPHANIE S OKEY, Form 1442026-03-02: Tobin Schilke, Form 1442026-02-02: DANA PIZZUTI, Form 1442026-01-05: ISABEL KALOFONOS, Form 1442026-01-02: DANA PIZZUTI, Form 1442025-12-01: DANA PIZZUTI, Form 1442025-11-03: DANA PIZZUTI, Form 1442025-11-03: Pizzuti Dana, sold2025-12-01: Pizzuti Dana, sold2026-01-05: Kalofonos Isabel, sold2026-03-03: Schilke Tobin, sold2026-03-03: Okey Stephanie, sold2026-03-12: Vivaldi Coelho Rogerio, sold2026-03-16: Struthers Richard Scott, sold2026-03-16: Betz Stephen F., sold2026-03-16: Knight Jeff E., sold2026-04-08: Knight Jeff E., sold2026-06-17: Okey Stephanie, sold2026-07-02: Vivaldi Coelho Rogerio, sold
under a ▼ salesize is dollars

Form 144 notices, newest first

2026-07-02JEFF KNIGHT, Chief Dev. & Operating Officer$1,834,206
47,420 shplan 2025-12-12no Form 4 on file yet144 ↗
2026-07-02ROGERIO VIVALDI COELHO, Director$232,080
6,000 shplan 2025-12-11144 ↗
Form 4, 2026-07-07: sold 3,000 at $40.00 Form 4 ↗
2026-06-17STEPHANIE OKEY, Director$241,500
6,900 shplan 2025-11-19144 ↗
Form 4, 2026-06-18: sold 6,900 at $35.67 Form 4 ↗
2026-05-04JEFF KNIGHT, Chief Dev. & Operating Officer$370,105
9,485 shplan 2025-12-12no Form 4 on file144 ↗
2026-04-14JEFF KNIGHT, Chief Dev. & Operating Officer$807,994
20,900 shplan 2025-12-12no Form 4 on file144 ↗
2026-04-13JEFF KNIGHT, Chief Dev. & Operating Officer$174,877
4,434 shplan 2025-12-12no Form 4 on file144 ↗
2026-04-08JEFF KNIGHT, Chief Dev. & Operating Officer$3,271,111
85,163 shplan 2025-12-12144 ↗
Form 4, 2026-04-10: sold 85,163 at $40.10 Form 4 ↗
2026-03-18DANA PIZZUTI, Chief Med and Dev Officer$938,005
24,756 shplan 2025-05-21no Form 4 on file144 ↗
2026-03-16Jeff Knight, Chief Dev. & Operating Officer$941,486
25,113 shplan 2025-12-12144 ↗
Form 4, 2026-03-18: sold 9,911 at $37.37 Form 4 ↗
2026-03-16Stephen Betz, Chief Scientific Officer$994,422
26,525 shplan 2026-02-19144 ↗
Form 4, 2026-03-18: sold 10,612 at $37.37 Form 4 ↗
2026-03-16Richard Scott Struthers, President & CEO$1,687,537
45,013 sh10b5-1 plan144 ↗
Form 4, 2026-03-18: sold 21,981 at $37.37 Form 4 ↗
2026-03-12ROGERIO VIVALDI COELHO, Director$184,900
5,000 shplan 2025-12-11144 ↗
Form 4, 2026-03-13: sold 5,000 at $36.15 Form 4 ↗
2026-03-03STEPHANIE S OKEY, Director$122,040
3,000 shplan 2025-11-19144 ↗
Form 4, 2026-03-04: sold 3,000 at $39.67 Form 4 ↗
2026-03-02Tobin Schilke, Chief Financial & Infra. Ofcr.$280,000
6,800 shplan 2025-11-10144 ↗
Form 4, 2026-03-04: sold 6,713 at $39.67 Form 4 ↗
2026-02-02DANA PIZZUTI, Chief Med and Dev Officer$499,400
10,000 shplan 2025-05-21no Form 4 on file144 ↗
2026-01-05ISABEL KALOFONOS, Chief Commercial Officer$116,825
2,500 shplan 2025-06-07144 ↗
Form 4, 2026-01-07: sold 2,500 at $55.00 Form 4 ↗
2026-01-02DANA PIZZUTI, Chief Med and Dev Officer$232,750
5,000 shplan 2025-05-21no Form 4 on file144 ↗
2025-12-01DANA PIZZUTI, Chief Med and Dev Officer$227,800
5,000 shplan 2025-05-21144 ↗
Form 4, 2025-12-03: sold 5,000 at $45.02 Form 4 ↗
2025-11-03DANA PIZZUTI, Chief Med and Dev Officer$217,500
5,000 shplan 2025-05-21144 ↗
Form 4, 2025-11-05: sold 5,000 at $42.66 Form 4 ↗